aluates Reports

$ 0.0

Automative

Global Musculoskeletal System Disorder Drug Market Research Report 2024

Published Date: November 2024

Report Code: QYRE-Auto-25N18321

BUY CHAPTERS

Global Musculoskeletal System Disorder Drug Market Research Report 2024

Code: QYRE-Auto-25N18321

Report

November 2024

Pages:96

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Pfizer Inc

Johnson & Johnson

GSK

Bayer

Eli Lilly

Novartis

Sanofi

Abbott

Merck

Asahi Kasei

Nippon Shinyaku

Eisai Co Ltd

Cadila Healthcare

Torrent Pharmaceuticals

Amgen Inc

Astellas Pharma

Musculoskeletal System Disorder Drug Market Size

The global Musculoskeletal System Disorder Drug market was valued at US$ 15780 million in 2023 and is anticipated to reach US$ 30100 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.

Musculoskeletal System Disorder Drug Market

Musculoskeletal system disorder drugs are medications designed to treat diseases affecting the muscles, bones, and joints. These drugs aim to relieve pain, reduce inflammation, and improve joint mobility, providing support for patients dealing with conditions such as arthritis, osteoporosis, and muscle injuries. Common categories of these drugs include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, analgesics, bone-protecting agents, and muscle relaxants, with treatments selected based on the patient’s symptoms and disease progression.

North American market for Musculoskeletal System Disorder Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Musculoskeletal System Disorder Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Musculoskeletal System Disorder Drug in Hospital & Clinic is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Musculoskeletal System Disorder Drug include AbbVie, Pfizer, Johnson & Johnson, GSK, Bayer, Eli Lilly, Novartis, Sanofi, Abbott, Merck & Co, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Musculoskeletal System Disorder Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Musculoskeletal System Disorder Drug.

The Musculoskeletal System Disorder Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Musculoskeletal System Disorder Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Musculoskeletal System Disorder Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Musculoskeletal System Disorder Drug Market Report

Report Metric	Details
Report Name	Musculoskeletal System Disorder Drug Market
Accounted market size in 2023	US$ 15780 million
Forecasted market size in 2030	US$ 30100 million
CAGR	4.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Joint Disorder Bone Disorder Muscle Disorder Other
Segment by Application	Hospital & Clinic Retail Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Pfizer, Johnson & Johnson, GSK, Bayer, Eli Lilly, Novartis, Sanofi, Abbott, Merck & Co, Asahi Kasei, Nippon Shinyaku, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen, Astellas Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Musculoskeletal System Disorder Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Musculoskeletal System Disorder Drug Market growing?

Ans: The Musculoskeletal System Disorder Drug Market witnessing a CAGR of 4.9% during the forecast period 2024-2030.

What is the Musculoskeletal System Disorder Drug Market size in 2030?

Ans: The Musculoskeletal System Disorder Drug Market size in 2030 will be US$ 30100 million.

Who are the main players in the Musculoskeletal System Disorder Drug Market report?

Ans: The main players in the Musculoskeletal System Disorder Drug Market are AbbVie, Pfizer, Johnson & Johnson, GSK, Bayer, Eli Lilly, Novartis, Sanofi, Abbott, Merck & Co, Asahi Kasei, Nippon Shinyaku, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen, Astellas Pharma

What are the Application segmentation covered in the Musculoskeletal System Disorder Drug Market report?

Ans: The Applications covered in the Musculoskeletal System Disorder Drug Market report are Hospital & Clinic, Retail Pharmacy, Other

What are the Type segmentation covered in the Musculoskeletal System Disorder Drug Market report?

Ans: The Types covered in the Musculoskeletal System Disorder Drug Market report are Joint Disorder, Bone Disorder, Muscle Disorder, Other

Recommended Reports

Pain & Muscle Therapy

Inflammation & Immune

Musculoskeletal Disorders

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Musculoskeletal System Disorder Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Joint Disorder

1.2.3 Bone Disorder

1.2.4 Muscle Disorder

1.2.5 Other

1.3 Market by Application

1.3.1 Global Musculoskeletal System Disorder Drug Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital & Clinic

1.3.3 Retail Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Musculoskeletal System Disorder Drug Market Perspective (2019-2030)

2.2 Global Musculoskeletal System Disorder Drug Growth Trends by Region

2.2.1 Global Musculoskeletal System Disorder Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Musculoskeletal System Disorder Drug Historic Market Size by Region (2019-2024)

2.2.3 Musculoskeletal System Disorder Drug Forecasted Market Size by Region (2025-2030)

2.3 Musculoskeletal System Disorder Drug Market Dynamics

2.3.1 Musculoskeletal System Disorder Drug Industry Trends

2.3.2 Musculoskeletal System Disorder Drug Market Drivers

2.3.3 Musculoskeletal System Disorder Drug Market Challenges

2.3.4 Musculoskeletal System Disorder Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Musculoskeletal System Disorder Drug Players by Revenue

3.1.1 Global Top Musculoskeletal System Disorder Drug Players by Revenue (2019-2024)

3.1.2 Global Musculoskeletal System Disorder Drug Revenue Market Share by Players (2019-2024)

3.2 Global Musculoskeletal System Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Musculoskeletal System Disorder Drug Revenue

3.4 Global Musculoskeletal System Disorder Drug Market Concentration Ratio

3.4.1 Global Musculoskeletal System Disorder Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal System Disorder Drug Revenue in 2023

3.5 Global Key Players of Musculoskeletal System Disorder Drug Head office and Area Served

3.6 Global Key Players of Musculoskeletal System Disorder Drug, Product and Application

3.7 Global Key Players of Musculoskeletal System Disorder Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Musculoskeletal System Disorder Drug Breakdown Data by Type

4.1 Global Musculoskeletal System Disorder Drug Historic Market Size by Type (2019-2024)

4.2 Global Musculoskeletal System Disorder Drug Forecasted Market Size by Type (2025-2030)

5 Musculoskeletal System Disorder Drug Breakdown Data by Application

5.1 Global Musculoskeletal System Disorder Drug Historic Market Size by Application (2019-2024)

5.2 Global Musculoskeletal System Disorder Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Musculoskeletal System Disorder Drug Market Size (2019-2030)

6.2 North America Musculoskeletal System Disorder Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Musculoskeletal System Disorder Drug Market Size by Country (2019-2024)

6.4 North America Musculoskeletal System Disorder Drug Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Musculoskeletal System Disorder Drug Market Size (2019-2030)

7.2 Europe Musculoskeletal System Disorder Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Musculoskeletal System Disorder Drug Market Size by Country (2019-2024)

7.4 Europe Musculoskeletal System Disorder Drug Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Musculoskeletal System Disorder Drug Market Size (2019-2030)

8.2 Asia-Pacific Musculoskeletal System Disorder Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Musculoskeletal System Disorder Drug Market Size by Region (2019-2024)

8.4 Asia-Pacific Musculoskeletal System Disorder Drug Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Musculoskeletal System Disorder Drug Market Size (2019-2030)

9.2 Latin America Musculoskeletal System Disorder Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Musculoskeletal System Disorder Drug Market Size by Country (2019-2024)

9.4 Latin America Musculoskeletal System Disorder Drug Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Musculoskeletal System Disorder Drug Market Size (2019-2030)

10.2 Middle East & Africa Musculoskeletal System Disorder Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Country (2019-2024)

10.4 Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Musculoskeletal System Disorder Drug Introduction

11.1.4 AbbVie Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.1.5 AbbVie Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Musculoskeletal System Disorder Drug Introduction

11.2.4 Pfizer Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.2.5 Pfizer Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Details

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Musculoskeletal System Disorder Drug Introduction

11.3.4 Johnson & Johnson Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.3.5 Johnson & Johnson Recent Development

11.4 GSK

11.4.1 GSK Company Details

11.4.2 GSK Business Overview

11.4.3 GSK Musculoskeletal System Disorder Drug Introduction

11.4.4 GSK Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.4.5 GSK Recent Development

11.5 Bayer

11.5.1 Bayer Company Details

11.5.2 Bayer Business Overview

11.5.3 Bayer Musculoskeletal System Disorder Drug Introduction

11.5.4 Bayer Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.5.5 Bayer Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Details

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Musculoskeletal System Disorder Drug Introduction

11.6.4 Eli Lilly Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.6.5 Eli Lilly Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Musculoskeletal System Disorder Drug Introduction

11.7.4 Novartis Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.7.5 Novartis Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Details

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Musculoskeletal System Disorder Drug Introduction

11.8.4 Sanofi Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.8.5 Sanofi Recent Development

11.9 Abbott

11.9.1 Abbott Company Details

11.9.2 Abbott Business Overview

11.9.3 Abbott Musculoskeletal System Disorder Drug Introduction

11.9.4 Abbott Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.9.5 Abbott Recent Development

11.10 Merck & Co

11.10.1 Merck & Co Company Details

11.10.2 Merck & Co Business Overview

11.10.3 Merck & Co Musculoskeletal System Disorder Drug Introduction

11.10.4 Merck & Co Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.10.5 Merck & Co Recent Development

11.11 Asahi Kasei

11.11.1 Asahi Kasei Company Details

11.11.2 Asahi Kasei Business Overview

11.11.3 Asahi Kasei Musculoskeletal System Disorder Drug Introduction

11.11.4 Asahi Kasei Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.11.5 Asahi Kasei Recent Development

11.12 Nippon Shinyaku

11.12.1 Nippon Shinyaku Company Details

11.12.2 Nippon Shinyaku Business Overview

11.12.3 Nippon Shinyaku Musculoskeletal System Disorder Drug Introduction

11.12.4 Nippon Shinyaku Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.12.5 Nippon Shinyaku Recent Development

11.13 Eisai

11.13.1 Eisai Company Details

11.13.2 Eisai Business Overview

11.13.3 Eisai Musculoskeletal System Disorder Drug Introduction

11.13.4 Eisai Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.13.5 Eisai Recent Development

11.14 Cadila Healthcare

11.14.1 Cadila Healthcare Company Details

11.14.2 Cadila Healthcare Business Overview

11.14.3 Cadila Healthcare Musculoskeletal System Disorder Drug Introduction

11.14.4 Cadila Healthcare Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.14.5 Cadila Healthcare Recent Development

11.15 Torrent Pharmaceuticals

11.15.1 Torrent Pharmaceuticals Company Details

11.15.2 Torrent Pharmaceuticals Business Overview

11.15.3 Torrent Pharmaceuticals Musculoskeletal System Disorder Drug Introduction

11.15.4 Torrent Pharmaceuticals Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.15.5 Torrent Pharmaceuticals Recent Development

11.16 Amgen

11.16.1 Amgen Company Details

11.16.2 Amgen Business Overview

11.16.3 Amgen Musculoskeletal System Disorder Drug Introduction

11.16.4 Amgen Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.16.5 Amgen Recent Development

11.17 Astellas Pharma

11.17.1 Astellas Pharma Company Details

11.17.2 Astellas Pharma Business Overview

11.17.3 Astellas Pharma Musculoskeletal System Disorder Drug Introduction

11.17.4 Astellas Pharma Revenue in Musculoskeletal System Disorder Drug Business (2019-2024)

11.17.5 Astellas Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Pfizer Inc

Johnson & Johnson

GSK

Bayer

Eli Lilly

Novartis

Sanofi

Abbott

Merck

Asahi Kasei

Nippon Shinyaku

Eisai Co Ltd

Cadila Healthcare

Torrent Pharmaceuticals

Amgen Inc

Astellas Pharma

List of Tables

Table 1. Global Musculoskeletal System Disorder Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Joint Disorder

Table 3. Key Players of Bone Disorder

Table 4. Key Players of Muscle Disorder

Table 5. Key Players of Other

Table 6. Global Musculoskeletal System Disorder Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Musculoskeletal System Disorder Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Musculoskeletal System Disorder Drug Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Musculoskeletal System Disorder Drug Market Share by Region (2019-2024)

Table 10. Global Musculoskeletal System Disorder Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Musculoskeletal System Disorder Drug Market Share by Region (2025-2030)

Table 12. Musculoskeletal System Disorder Drug Market Trends

Table 13. Musculoskeletal System Disorder Drug Market Drivers

Table 14. Musculoskeletal System Disorder Drug Market Challenges

Table 15. Musculoskeletal System Disorder Drug Market Restraints

Table 16. Global Musculoskeletal System Disorder Drug Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Musculoskeletal System Disorder Drug Market Share by Players (2019-2024)

Table 18. Global Top Musculoskeletal System Disorder Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal System Disorder Drug as of 2023)

Table 19. Ranking of Global Top Musculoskeletal System Disorder Drug Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Musculoskeletal System Disorder Drug Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Musculoskeletal System Disorder Drug, Headquarters and Area Served

Table 22. Global Key Players of Musculoskeletal System Disorder Drug, Product and Application

Table 23. Global Key Players of Musculoskeletal System Disorder Drug, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Musculoskeletal System Disorder Drug Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Musculoskeletal System Disorder Drug Revenue Market Share by Type (2019-2024)

Table 27. Global Musculoskeletal System Disorder Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Musculoskeletal System Disorder Drug Revenue Market Share by Type (2025-2030)

Table 29. Global Musculoskeletal System Disorder Drug Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Musculoskeletal System Disorder Drug Revenue Market Share by Application (2019-2024)

Table 31. Global Musculoskeletal System Disorder Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Musculoskeletal System Disorder Drug Revenue Market Share by Application (2025-2030)

Table 33. North America Musculoskeletal System Disorder Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Musculoskeletal System Disorder Drug Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Musculoskeletal System Disorder Drug Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Musculoskeletal System Disorder Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Musculoskeletal System Disorder Drug Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Musculoskeletal System Disorder Drug Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Musculoskeletal System Disorder Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Musculoskeletal System Disorder Drug Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Musculoskeletal System Disorder Drug Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Musculoskeletal System Disorder Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Musculoskeletal System Disorder Drug Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Musculoskeletal System Disorder Drug Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Musculoskeletal System Disorder Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Country (2025-2030) & (US$ Million)

Table 48. AbbVie Company Details

Table 49. AbbVie Business Overview

Table 50. AbbVie Musculoskeletal System Disorder Drug Product

Table 51. AbbVie Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 52. AbbVie Recent Development

Table 53. Pfizer Company Details

Table 54. Pfizer Business Overview

Table 55. Pfizer Musculoskeletal System Disorder Drug Product

Table 56. Pfizer Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 57. Pfizer Recent Development

Table 58. Johnson & Johnson Company Details

Table 59. Johnson & Johnson Business Overview

Table 60. Johnson & Johnson Musculoskeletal System Disorder Drug Product

Table 61. Johnson & Johnson Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 62. Johnson & Johnson Recent Development

Table 63. GSK Company Details

Table 64. GSK Business Overview

Table 65. GSK Musculoskeletal System Disorder Drug Product

Table 66. GSK Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 67. GSK Recent Development

Table 68. Bayer Company Details

Table 69. Bayer Business Overview

Table 70. Bayer Musculoskeletal System Disorder Drug Product

Table 71. Bayer Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 72. Bayer Recent Development

Table 73. Eli Lilly Company Details

Table 74. Eli Lilly Business Overview

Table 75. Eli Lilly Musculoskeletal System Disorder Drug Product

Table 76. Eli Lilly Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 77. Eli Lilly Recent Development

Table 78. Novartis Company Details

Table 79. Novartis Business Overview

Table 80. Novartis Musculoskeletal System Disorder Drug Product

Table 81. Novartis Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 82. Novartis Recent Development

Table 83. Sanofi Company Details

Table 84. Sanofi Business Overview

Table 85. Sanofi Musculoskeletal System Disorder Drug Product

Table 86. Sanofi Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 87. Sanofi Recent Development

Table 88. Abbott Company Details

Table 89. Abbott Business Overview

Table 90. Abbott Musculoskeletal System Disorder Drug Product

Table 91. Abbott Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 92. Abbott Recent Development

Table 93. Merck & Co Company Details

Table 94. Merck & Co Business Overview

Table 95. Merck & Co Musculoskeletal System Disorder Drug Product

Table 96. Merck & Co Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 97. Merck & Co Recent Development

Table 98. Asahi Kasei Company Details

Table 99. Asahi Kasei Business Overview

Table 100. Asahi Kasei Musculoskeletal System Disorder Drug Product

Table 101. Asahi Kasei Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 102. Asahi Kasei Recent Development

Table 103. Nippon Shinyaku Company Details

Table 104. Nippon Shinyaku Business Overview

Table 105. Nippon Shinyaku Musculoskeletal System Disorder Drug Product

Table 106. Nippon Shinyaku Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 107. Nippon Shinyaku Recent Development

Table 108. Eisai Company Details

Table 109. Eisai Business Overview

Table 110. Eisai Musculoskeletal System Disorder Drug Product

Table 111. Eisai Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 112. Eisai Recent Development

Table 113. Cadila Healthcare Company Details

Table 114. Cadila Healthcare Business Overview

Table 115. Cadila Healthcare Musculoskeletal System Disorder Drug Product

Table 116. Cadila Healthcare Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 117. Cadila Healthcare Recent Development

Table 118. Torrent Pharmaceuticals Company Details

Table 119. Torrent Pharmaceuticals Business Overview

Table 120. Torrent Pharmaceuticals Musculoskeletal System Disorder Drug Product

Table 121. Torrent Pharmaceuticals Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 122. Torrent Pharmaceuticals Recent Development

Table 123. Amgen Company Details

Table 124. Amgen Business Overview

Table 125. Amgen Musculoskeletal System Disorder Drug Product

Table 126. Amgen Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 127. Amgen Recent Development

Table 128. Astellas Pharma Company Details

Table 129. Astellas Pharma Business Overview

Table 130. Astellas Pharma Musculoskeletal System Disorder Drug Product

Table 131. Astellas Pharma Revenue in Musculoskeletal System Disorder Drug Business (2019-2024) & (US$ Million)

Table 132. Astellas Pharma Recent Development

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Musculoskeletal System Disorder Drug Picture

Figure 2. Global Musculoskeletal System Disorder Drug Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Musculoskeletal System Disorder Drug Market Share by Type: 2023 VS 2030

Figure 4. Joint Disorder Features

Figure 5. Bone Disorder Features

Figure 6. Muscle Disorder Features

Figure 7. Other Features

Figure 8. Global Musculoskeletal System Disorder Drug Market Size by Application (2024-2030) & (US$ Million)

Figure 9. Global Musculoskeletal System Disorder Drug Market Share by Application: 2023 VS 2030

Figure 10. Hospital & Clinic Case Studies

Figure 11. Retail Pharmacy Case Studies

Figure 12. Other Case Studies

Figure 13. Musculoskeletal System Disorder Drug Report Years Considered

Figure 14. Global Musculoskeletal System Disorder Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Musculoskeletal System Disorder Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Musculoskeletal System Disorder Drug Market Share by Region: 2023 VS 2030

Figure 17. Global Musculoskeletal System Disorder Drug Market Share by Players in 2023

Figure 18. Global Top Musculoskeletal System Disorder Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal System Disorder Drug as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Musculoskeletal System Disorder Drug Revenue in 2023

Figure 20. North America Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Musculoskeletal System Disorder Drug Market Share by Country (2019-2030)

Figure 22. United States Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Musculoskeletal System Disorder Drug Market Share by Country (2019-2030)

Figure 26. Germany Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Musculoskeletal System Disorder Drug Market Share by Region (2019-2030)

Figure 34. China Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Musculoskeletal System Disorder Drug Market Share by Country (2019-2030)

Figure 42. Mexico Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Musculoskeletal System Disorder Drug Market Share by Country (2019-2030)

Figure 46. Turkey Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. UAE Musculoskeletal System Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. AbbVie Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 50. Pfizer Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 51. Johnson & Johnson Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 52. GSK Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 53. Bayer Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 54. Eli Lilly Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 55. Novartis Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 56. Sanofi Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 57. Abbott Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 58. Merck & Co Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 59. Asahi Kasei Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 60. Nippon Shinyaku Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 61. Eisai Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 62. Cadila Healthcare Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 63. Torrent Pharmaceuticals Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 64. Amgen Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 65. Astellas Pharma Revenue Growth Rate in Musculoskeletal System Disorder Drug Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Drugs for Musculoskeletal Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Musculoskeletal System Disorder Market Insights Forecast to 2030

Global Musculoskeletal Disorders Therapeutics Market Research Report 2025

MSD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Musculoskeletal Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Rheumatic Drugs Market Research Report 2024

MSD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Skeletal Muscle Relaxants Market Research Report 2025

Global Musculoskeletal Disorder Stem Cell Therapy Market Insights Forecast to 2030

Muscle Relaxers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Muscle Relaxant Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Musculoskeletal Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025

Global Autoimmune Disease Drugs Market Research Report 2025

Global Lower Back Pain Drug Market Research Report 2025

Global Osteoarthritis Pain Drugs Market Insights Forecast to 2030

Global Chronic Pain Therapy Solutions for Joints Market Research Report 2024

Musculoskeletal Tumor Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Systemic Autoinflammatory Diseases Drug Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions